Reference SummaryHighman B, J Environ Pathol Toxicol 1980 Nov;4(5-6):81-95
Title |
Neoplastic and preneoplastic lesions induced in female C3H mice by diets containing diethylstilbestrol or 17 beta-estradiol. |
Authors |
Highman B; Greenman DL; Norvell MJ; Farmer J; Shellenberger TE |
Journal |
J Environ Pathol Toxicol |
Volume |
4 |
Issue |
5-6 |
Year |
1980 |
Pages |
81-95 |
Abstract |
To study the long term effects of estrogenic diets, 2160 virgin female C3H/Hel mice, having a high titer to the mammary tumor virus factor (MMTV), were fed diets containing 0, 10, 100, 500, or 1000 ppb diethylstilbestrol (DES) or 100, 1000, or 5000 ppb 17 beta-estradiol (E2) from 6 to 110 weeks of age; 1368 virgin female C3HeB/FeJ mice, having a low titer to the MMTV, were fed diets containing 0, 10, 1000, or 500 ppb DES from 6 to 136 weeks. In estrogen-treated mice, the incidence of cervical adenosis and of mammary hyperplastic alveolar nodules was increased and the time to development of mammary adenocarcinomas was shortened. These changes tended to increase with dose and time and appeared earlier in the C3H/HeJ mice. Other tumors observed included 32 cervical and 20 endometrial adenocarcinomas, 16 cervical granular cell myoblastomas, 12 peritoneal mesotheliomas involving the uterus, 2 cervical and 4 vaginal squamous cell carcinomas, 2 ovarian teratomas, 6 osteosarcomas, 25 pheochromocytomas and 3 thyroid carcinomas. Of these tumors, 1 cervical and 2 endometrial adenocarcinomas, and 4 pheochromocytomas occurred in C3HeB/FeJ control mice at 104-130 weeks; none occurred in C3H/HeJ controls. This study indicates that the MMTV facilitates the development of mammary lesions in C3H mice, that estrogens predispose C3H mice to endometrial and cervical adenocarcinomas, and that cervical adenosis may be a precursor of cervical adenocarcinoma in C3H mice and serve as an early indicator of the potential uterine carcinogenicity of a test compound. It supports the view that the C3H mouse may serve as an animal model for uterine adenocarcinomas and adenosis in women exposed to estrogens. |
Links |
J:237477 – MGI References 7217862 – National Library of Medicine/PubMed |
Strain | Model Name | Treatment Agent(s) | Organ Affected | Frequency | Model Details |
---|---|---|---|---|---|
C3H/HeJ | Adrenal gland - Medulla hyperplasia |
|
Adrenal gland - Medulla |
observed |
|
C3H/HeJ | Adrenal gland - Medulla hyperplasia |
|
Adrenal gland - Medulla |
observed |
|
C3H/HeJ | Adrenal gland - Medulla hyperplasia |
|
Adrenal gland - Medulla |
observed |
|
C3H/HeJ | Adrenal gland - Medulla pheochromocytoma |
|
Adrenal gland - Medulla |
0 |
|
C3H/HeJ | Adrenal gland - Medulla pheochromocytoma |
|
Adrenal gland - Medulla |
observed |
|
C3H/HeJ | Adrenal gland - Medulla pheochromocytoma |
|
Adrenal gland - Medulla |
observed |
|
C3H/HeJ | Adrenal gland - Medulla pheochromocytoma |
|
Adrenal gland - Medulla |
0 |
|
C3H/HeJ | Adrenal gland - Medulla pheochromocytoma |
|
Adrenal gland - Medulla |
observed |
|
C3H/HeJ | Adrenal gland - Medulla pheochromocytoma |
|
Adrenal gland - Medulla |
0 - observed |
|
C3HeB/FeJ | Adrenal gland - Medulla pheochromocytoma |
|
Adrenal gland - Medulla |
observed |
|
C3HeB/FeJ | Adrenal gland - Medulla pheochromocytoma |
|
Adrenal gland - Medulla |
observed |
|
C3HeB/FeJ | Adrenal gland - Medulla pheochromocytoma |
|
Adrenal gland - Medulla |
observed |
|
C3H/HeJ | Bone osteosarcoma |
|
Bone |
observed |
|
C3H/HeJ | Bone osteosarcoma |
|
Bone |
0 |
|
C3H/HeJ | Bone osteosarcoma |
|
Bone |
observed |
|
C3H/HeJ | Bone osteosarcoma |
|
Bone |
observed |
|
C3H/HeJ | Bone osteosarcoma |
|
Bone |
0 |
|
C3H/HeJ | Bone osteosarcoma |
|
Bone |
0 |
|
C3HeB/FeJ | Bone osteosarcoma |
|
Bone |
0 |
|
C3HeB/FeJ | Bone osteosarcoma |
|
Bone |
observed |
|
C3HeB/FeJ | Bone osteosarcoma |
|
Bone |
observed |
|
C3H/HeJ | Liver hepatocellular adenoma |
|
Liver |
1.24 |
|
C3H/HeJ | Liver hepatocellular adenoma |
|
Liver |
1.54 |
|
C3H/HeJ | Liver hepatocellular adenoma |
|
Liver |
1.4 |
|
C3HeB/FeJ | Liver hepatocellular adenoma |
|
Liver |
1.45 |
|
C3HeB/FeJ | Liver hepatocellular adenoma |
|
Liver |
2.13 |
|
C3H/HeJ | Liver hepatocellular carcinoma |
|
Liver |
1.65 |
|
C3H/HeJ | Liver hepatocellular carcinoma |
|
Liver |
0.92 |
|
C3H/HeJ | Liver hepatocellular carcinoma |
|
Liver |
1.4 |
|
C3HeB/FeJ | Liver hepatocellular carcinoma |
|
Liver |
10.14 |
|
C3HeB/FeJ | Liver hepatocellular carcinoma |
|
Liver |
5.33 |
|
C3H/HeJ | Mammary gland adenocarcinoma |
|
Mammary gland |
4.4 - 38 |
|
C3H/HeJ | Mammary gland adenocarcinoma |
|
Mammary gland |
4.3 - 100 |
|
C3H/HeJ | Mammary gland adenocarcinoma |
|
Mammary gland |
6.9 - 50 |
|
C3H/HeJ | Mammary gland adenocarcinoma |
|
Mammary gland |
45.31 - 53.85 |
|
C3H/HeJ | Mammary gland adenocarcinoma |
|
Mammary gland |
0 - 57.89 |
|
C3H/HeJ | Mammary gland adenocarcinoma |
|
Mammary gland |
4.26 - 47.06 |
|
C3H/HeJ | Mammary gland adenocarcinoma |
|
Mammary gland |
5.38 - 44.44 |
|
C3HeB/FeJ | Mammary gland adenocarcinoma |
|
Mammary gland |
2.63 - 51.28 |
|
C3HeB/FeJ | Mammary gland adenocarcinoma |
|
Mammary gland |
0 - 60 |
|
C3HeB/FeJ | Mammary gland adenocarcinoma |
|
Mammary gland |
0 - 20.45 |
|
C3H/HeJ | Mammary gland adenocarcinoma |
|
Mammary gland |
26.32 - 44.83 |
|
C3H/HeJ | Mammary gland adenocarcinoma |
|
Mammary gland |
19.51 - 50 |
|
C3H/HeJ | Mammary gland adenocarcinoma |
|
Mammary gland |
37.5 |
|
C3H/HeJ | Mammary gland adenocarcinoma |
|
Mammary gland |
42.11 - 43.59 |
|
C3H/HeJ | Mammary gland adenocarcinoma |
|
Mammary gland |
50 |
|
C3H/HeJ | Mammary gland adenocarcinoma |
|
Mammary gland |
58.33 |
|
C3H/HeJ | Mammary gland adenocarcinoma |
|
Mammary gland |
27.27 - 38.1 |
|
C3H/HeJ | Mammary gland adenocarcinoma - type A |
|
Mammary gland |
observed |
|
C3H/HeJ | Mammary gland adenocarcinoma - type A |
|
Mammary gland |
observed |
|
C3H/HeJ | Mammary gland adenocarcinoma - type A |
|
Mammary gland |
observed |
|
C3H/HeJ | Mammary gland adenocarcinoma - type B |
|
Mammary gland |
observed |
|
C3H/HeJ | Mammary gland adenocarcinoma - type B |
|
Mammary gland |
observed |
|
C3H/HeJ | Mammary gland adenocarcinoma - type B |
|
Mammary gland |
observed |
|
C3H/HeJ | Mammary gland adenocarcinoma - type C |
|
Mammary gland |
observed |
|
C3H/HeJ | Mammary gland adenocarcinoma - type C |
|
Mammary gland |
very low |
|
C3H/HeJ | Mammary gland adenocarcinoma - type C |
|
Mammary gland |
very low |
|
C3HeB/FeJ | Mammary gland carcinoma |
|
Mammary gland |
8.11 |
|
C3H/HeJ | Mammary gland foci |
|
Mammary gland |
observed |
|
C3H/HeJ | Mammary gland foci |
|
Mammary gland |
observed |
|
C3H/HeJ | Mammary gland hyperplasia - alveolar |
|
Mammary gland |
0 - 12 |
|
C3H/HeJ | Mammary gland hyperplasia - alveolar |
|
Mammary gland |
0 - observed |
|
C3H/HeJ | Mammary gland hyperplasia - alveolar |
|
Mammary gland |
0 - 3.23 |
|
C3H/HeJ | Mammary gland hyperplasia - alveolar |
|
Mammary gland |
0 - 75 |
|
C3H/HeJ | Mammary gland hyperplasia - alveolar |
|
Mammary gland |
5.13 - 61.54 |
|
C3H/HeJ | Mammary gland hyperplasia - alveolar |
|
Mammary gland |
0 - 35.29 |
|
C3H/HeJ | Mammary gland hyperplasia - alveolar |
|
Mammary gland |
0 - 27.59 |
|
C3H/HeJ | Mammary gland hyperplasia - alveolar |
|
Mammary gland |
0 - 33.33 |
|
C3HeB/FeJ | Mammary gland hyperplasia - alveolar |
|
Mammary gland |
0 - 5.41 |
|
C3HeB/FeJ | Mammary gland hyperplasia - alveolar |
|
Mammary gland |
0 - 40 |
|
C3HeB/FeJ | Mammary gland hyperplasia - alveolar |
|
Mammary gland |
0 - 70 |
|
C3H/HeJ | Mammary gland hyperplasia - alveolar |
|
Mammary gland |
0 - 10.34 |
|
C3H/HeJ | Mammary gland hyperplasia - alveolar |
|
Mammary gland |
2.44 - 19.05 |
|
C3H/HeJ | Mammary gland hyperplasia - alveolar |
|
Mammary gland |
0 - 12.12 |
|
C3H/HeJ | Mammary gland hyperplasia - alveolar |
|
Mammary gland |
0 - 26.32 |
|
C3H/HeJ | Mammary gland lesion |
|
Mammary gland |
observed |
|
C3H/HeJ | Mammary gland lesion |
|
Mammary gland |
observed |
|
C3H/HeJ | Mammary gland tumor |
|
Mammary gland |
53.85 |
|
C3H/HeJ | Mesothelium mesothelioma |
|
Uterus |
0 |
|
C3H/HeJ | Mesothelium mesothelioma |
|
Uterus |
0 |
|
C3H/HeJ | Mesothelium mesothelioma |
|
Uterus |
0 |
|
C3H/HeJ | Mesothelium mesothelioma |
|
Uterus |
observed |
|
C3H/HeJ | Mesothelium mesothelioma |
|
Uterus |
observed |
|
C3H/HeJ | Mesothelium mesothelioma |
|
Uterus |
0 |
|
C3H/HeJ | Mesothelium mesothelioma |
|
Uterus |
0 |
|
C3H/HeJ | Mesothelium mesothelioma |
|
Uterus |
observed |
|
C3HeB/FeJ | Mesothelium mesothelioma |
|
Uterus |
0 |
|
C3HeB/FeJ | Mesothelium mesothelioma |
|
Uterus |
0 |
|
C3HeB/FeJ | Mesothelium mesothelioma |
|
Uterus |
observed |
|
C3H/HeJ | Ovary - Germ cell teratoma |
|
Ovary - Germ cell |
0 |
|
C3H/HeJ | Ovary - Germ cell teratoma |
|
Ovary - Germ cell |
0 |
|
C3H/HeJ | Ovary - Germ cell teratoma |
|
Ovary - Germ cell |
0 |
|
C3H/HeJ | Ovary - Germ cell teratoma |
|
Ovary - Germ cell |
0 |
|
C3H/HeJ | Ovary - Germ cell teratoma |
|
Ovary - Germ cell |
observed |
|
C3HeB/FeJ | Ovary - Germ cell teratoma |
|
Ovary - Germ cell |
0 |
|
C3HeB/FeJ | Ovary - Germ cell teratoma |
|
Ovary - Germ cell |
0 |
|
C3HeB/FeJ | Ovary - Germ cell teratoma |
|
Ovary - Germ cell |
observed |
|
C3H/HeJ | Ovary - Granulosa cell tumor |
|
Ovary - Granulosa cell |
3.4 |
|
C3HeB/FeJ | Ovary - Granulosa cell tumor |
|
Ovary - Granulosa cell |
5.3 |
|
C3H/HeJ | Ovary adenoma - tubular |
|
Ovary |
14.29 - 50 |
|
C3H/HeJ | Ovary adenoma - tubular |
|
Ovary |
20.83 - 63.64 |
|
C3H/HeJ | Ovary adenoma - tubular |
|
Ovary |
47.5 |
|
C3H/HeJ | Ovary adenoma - tubular |
|
Ovary |
33.33 - 100 |
|
C3H/HeJ | Ovary adenoma - tubular |
|
Ovary |
33.33 |
|
C3H/HeJ | Ovary adenoma - tubular |
|
Ovary |
0 - 60 |
|
C3H/HeJ | Ovary adenoma - tubular |
|
Ovary |
42.86 - 44 |
|
C3H/HeJ | Ovary adenoma - tubular |
|
Ovary |
12.5 |
|
C3HeB/FeJ | Ovary adenoma - tubular |
|
Ovary |
0 - 36.36 |
|
C3HeB/FeJ | Ovary adenoma - tubular |
|
Ovary |
8.82 - 11.9 |
|
C3HeB/FeJ | Ovary adenoma - tubular |
|
Ovary |
0 - 50 |
|
C3H/HeJ | Ovary luteoma |
|
Ovary |
3.0 |
|
C3HeB/FeJ | Ovary luteoma |
|
Ovary |
2.1 |
|
C3H/HeJ | Pancreas - Islet of Langerhans adenoma |
|
Pancreas - Islet of Langerhans |
0 |
|
C3H/HeJ | Pancreas - Islet of Langerhans adenoma |
|
Pancreas - Islet of Langerhans |
observed |
|
C3H/HeJ | Pancreas - Islet of Langerhans adenoma |
|
Pancreas - Islet of Langerhans |
0 |
|
C3H/HeJ | Pancreas - Islet of Langerhans adenoma |
|
Pancreas - Islet of Langerhans |
observed |
|
C3H/HeJ | Pancreas - Islet of Langerhans adenoma |
|
Pancreas - Islet of Langerhans |
0 - observed |
|
C3HeB/FeJ | Pancreas - Islet of Langerhans adenoma |
|
Pancreas - Islet of Langerhans |
observed |
|
C3HeB/FeJ | Pancreas - Islet of Langerhans adenoma |
|
Pancreas - Islet of Langerhans |
0 |
|
C3HeB/FeJ | Pancreas - Islet of Langerhans adenoma |
|
Pancreas - Islet of Langerhans |
0 - observed |
|
C3H/HeJ | Pituitary gland adenoma |
|
Pituitary gland |
0 |
|
C3H/HeJ | Pituitary gland adenoma |
|
Pituitary gland |
observed |
|
C3H/HeJ | Pituitary gland adenoma |
|
Pituitary gland |
0 |
|
C3H/HeJ | Pituitary gland adenoma |
|
Pituitary gland |
0 |
|
C3H/HeJ | Pituitary gland adenoma |
|
Pituitary gland |
observed |
|
C3H/HeJ | Pituitary gland adenoma |
|
Pituitary gland |
0 - observed |
|
C3HeB/FeJ | Pituitary gland adenoma |
|
Pituitary gland |
observed |
|
C3HeB/FeJ | Pituitary gland adenoma |
|
Pituitary gland |
0 |
|
C3HeB/FeJ | Pituitary gland adenoma |
|
Pituitary gland |
observed |
|
C3H/HeJ | Skin squamous cell carcinoma |
|
Skin |
0 |
|
C3H/HeJ | Skin squamous cell carcinoma |
|
Skin |
observed |
|
C3H/HeJ | Skin squamous cell carcinoma |
|
Skin |
0 |
|
C3H/HeJ | Skin squamous cell carcinoma |
|
Skin |
0 |
|
C3H/HeJ | Skin squamous cell carcinoma |
|
Skin |
0 |
|
C3H/HeJ | Skin squamous cell carcinoma |
|
Skin |
0 |
|
C3H/HeJ | Skin squamous cell carcinoma |
|
Skin |
0 |
|
C3HeB/FeJ | Skin squamous cell carcinoma |
|
Skin |
0 |
|
C3HeB/FeJ | Skin squamous cell carcinoma |
|
Skin |
observed |
|
C3HeB/FeJ | Skin squamous cell carcinoma |
|
Skin |
observed |
|
C3H/HeJ | Thyroid gland carcinoma |
|
Thyroid gland |
0 |
|
C3H/HeJ | Thyroid gland carcinoma |
|
Thyroid gland |
0 |
|
C3H/HeJ | Thyroid gland carcinoma |
|
Thyroid gland |
0 |
|
C3H/HeJ | Thyroid gland carcinoma |
|
Thyroid gland |
observed |
|
C3H/HeJ | Thyroid gland carcinoma |
|
Thyroid gland |
0 |
|
C3H/HeJ | Thyroid gland carcinoma |
|
Thyroid gland |
0 |
|
C3H/HeJ | Thyroid gland carcinoma |
|
Thyroid gland |
0 |
|
C3HeB/FeJ | Thyroid gland carcinoma |
|
Thyroid gland |
0 |
|
C3HeB/FeJ | Thyroid gland carcinoma |
|
Thyroid gland |
0 - observed |
|
C3H/HeJ | Uterus - Cervix adenocarcinoma |
|
Uterus - Cervix |
0 |
|
C3H/HeJ | Uterus - Cervix adenocarcinoma |
|
Uterus - Cervix |
0 |
|
C3H/HeJ | Uterus - Cervix adenocarcinoma |
|
Uterus - Cervix |
observed |
|
C3H/HeJ | Uterus - Cervix adenocarcinoma |
|
Uterus - Cervix |
observed |
|
C3H/HeJ | Uterus - Cervix adenocarcinoma |
|
Uterus - Cervix |
observed |
|
C3H/HeJ | Uterus - Cervix adenocarcinoma |
|
Uterus - Cervix |
0 |
|
C3H/HeJ | Uterus - Cervix adenocarcinoma |
|
Uterus - Cervix |
observed |
|
C3HeB/FeJ | Uterus - Cervix adenocarcinoma |
|
Uterus - Cervix |
observed |
|
C3HeB/FeJ | Uterus - Cervix adenocarcinoma |
|
Uterus - Cervix |
observed |
|
C3HeB/FeJ | Uterus - Cervix adenocarcinoma |
|
Uterus - Cervix |
observed |
|
C3H/HeJ | Uterus - Cervix adenocarcinoma |
|
Uterus - Cervix |
observed |
|
C3H/HeJ | Uterus - Cervix adenocarcinoma |
|
Urethra |
observed |
|
C3H/HeJ | Uterus - Cervix adenocarcinoma |
|
Ureter |
observed |
|
C3H/HeJ | Uterus - Cervix adenocarcinoma |
|
Vagina |
observed |
|
C3H/HeJ | Uterus - Cervix adenocarcinoma |
|
Intestine - Large Intestine - Rectum |
observed |
|
C3HeB/FeJ | Uterus - Cervix adenocarcinoma |
|
Uterus - Cervix |
observed |
|
C3HeB/FeJ | Uterus - Cervix adenocarcinoma |
|
Urinary bladder |
observed |
|
C3HeB/FeJ | Uterus - Cervix adenocarcinoma |
|
Urethra |
observed |
|
C3HeB/FeJ | Uterus - Cervix adenocarcinoma |
|
Ureter |
observed |
|
C3HeB/FeJ | Uterus - Cervix adenocarcinoma |
|
Vagina |
observed |
|
C3HeB/FeJ | Uterus - Cervix adenocarcinoma |
|
Intestine - Large Intestine - Rectum |
observed |
|
C3HeB/FeJ | Uterus - Cervix adenocarcinoma |
|
Uterus |
observed |
|
C3H/HeJ | Uterus - Cervix lesion |
|
Uterus - Cervix |
5.41 - 15.79 |
|
C3H/HeJ | Uterus - Cervix lesion |
|
Uterus - Cervix |
7.14 |
|
C3H/HeJ | Uterus - Cervix lesion |
|
Uterus - Cervix |
6.82 - 27.91 |
|
C3H/HeJ | Uterus - Cervix lesion |
|
Uterus - Cervix |
14.29 - 83.33 |
|
C3H/HeJ | Uterus - Cervix lesion |
|
Uterus - Cervix |
0 - 41.18 |
|
C3H/HeJ | Uterus - Cervix lesion |
|
Uterus - Cervix |
41.67 - 97.78 |
|
C3H/HeJ | Uterus - Cervix lesion |
|
Uterus - Cervix |
64.29 |
|
C3H/HeJ | Uterus - Cervix lesion |
|
Uterus - Cervix |
2.7 - 59.52 |
|
C3H/HeJ | Uterus - Cervix lesion |
|
Uterus - Cervix |
11.11 - 57.14 |
|
C3H/HeJ | Uterus - Cervix lesion |
|
Uterus - Cervix |
21.43 - 50 |
|
C3H/HeJ | Uterus - Cervix lesion |
|
Uterus - Cervix |
73.33 |
|
C3HeB/FeJ | Uterus - Cervix lesion |
|
Uterus - Cervix |
0 - 14.29 |
|
C3HeB/FeJ | Uterus - Cervix lesion |
|
Uterus - Cervix |
6.9 - 91.67 |
|
C3HeB/FeJ | Uterus - Cervix lesion |
|
Uterus - Cervix |
3.57 - 100 |
|
C3H/HeJ | Uterus - Cervix myoblastoma - granular cell |
|
Uterus - Cervix |
0 |
|
C3H/HeJ | Uterus - Cervix myoblastoma - granular cell |
|
Uterus - Cervix |
0 |
|
C3H/HeJ | Uterus - Cervix myoblastoma - granular cell |
|
Uterus - Cervix |
observed |
|
C3H/HeJ | Uterus - Cervix myoblastoma - granular cell |
|
Uterus - Cervix |
0 |
|
C3H/HeJ | Uterus - Cervix myoblastoma - granular cell |
|
Uterus - Cervix |
0 |
|
C3H/HeJ | Uterus - Cervix myoblastoma - granular cell |
|
Uterus - Cervix |
observed |
|
C3H/HeJ | Uterus - Cervix myoblastoma - granular cell |
|
Uterus - Cervix |
observed |
|
C3HeB/FeJ | Uterus - Cervix myoblastoma - granular cell |
|
Uterus - Cervix |
0 |
|
C3HeB/FeJ | Uterus - Cervix myoblastoma - granular cell |
|
Uterus - Cervix |
observed |
|
C3H/HeJ | Uterus - Cervix squamous cell carcinoma |
|
Uterus - Cervix |
0 |
|
C3H/HeJ | Uterus - Cervix squamous cell carcinoma |
|
Uterus - Cervix |
observed |
|
C3H/HeJ | Uterus - Cervix squamous cell carcinoma |
|
Uterus - Cervix |
0 |
|
C3H/HeJ | Uterus - Cervix squamous cell carcinoma |
|
Uterus - Cervix |
0 |
|
C3H/HeJ | Uterus - Cervix squamous cell carcinoma |
|
Uterus - Cervix |
0 |
|
C3H/HeJ | Uterus - Cervix squamous cell carcinoma |
|
Uterus - Cervix |
0 |
|
C3HeB/FeJ | Uterus - Cervix squamous cell carcinoma |
|
Uterus - Cervix |
0 |
|
C3HeB/FeJ | Uterus - Cervix squamous cell carcinoma |
|
Uterus - Cervix |
0 |
|
C3HeB/FeJ | Uterus - Cervix squamous cell carcinoma |
|
Uterus - Cervix |
0 - observed |
|
C3H/HeJ | Uterus - Endometrium carcinoma |
|
Uterus - Endometrium |
observed |
|
C3H/HeJ | Uterus - Endometrium carcinoma |
|
Uterus - Endometrium |
0 |
|
C3H/HeJ | Uterus - Endometrium carcinoma |
|
Uterus - Endometrium |
observed |
|
C3HeB/FeJ | Uterus - Endometrium carcinoma |
|
Uterus - Endometrium |
0 |
|
C3HeB/FeJ | Uterus - Endometrium carcinoma |
|
Uterus - Endometrium |
observed |
|
C3H/HeJ | Uterus - Endometrium polyp |
|
Uterus - Endometrium |
1.39 |
|
C3H/HeJ | Uterus - Endometrium polyp |
|
Uterus - Endometrium |
3.85 |
|
C3H/HeJ | Uterus - Endometrium polyp |
|
Uterus - Endometrium |
1.59 |
|
C3HeB/FeJ | Uterus - Endometrium polyp |
|
Uterus - Endometrium |
1.47 |
|
C3HeB/FeJ | Uterus - Endometrium polyp |
|
Uterus - Endometrium |
5.25 |
|
C3H/HeJ | Uterus - Uterine horn adenoacanthoma |
|
Uterus - Uterine horn |
0 |
|
C3H/HeJ | Uterus - Uterine horn adenoacanthoma |
|
Uterus - Uterine horn |
0 |
|
C3H/HeJ | Uterus - Uterine horn adenoacanthoma |
|
Uterus - Uterine horn |
0 |
|
C3H/HeJ | Uterus - Uterine horn adenoacanthoma |
|
Uterus - Uterine horn |
0 - observed |
|
C3H/HeJ | Uterus - Uterine horn adenoacanthoma |
|
Uterus - Uterine horn |
0 |
|
C3HeB/FeJ | Uterus - Uterine horn adenoacanthoma |
|
Uterus - Uterine horn |
0 |
|
C3HeB/FeJ | Uterus - Uterine horn adenoacanthoma |
|
Uterus - Uterine horn |
0 |
|
C3HeB/FeJ | Uterus - Uterine horn adenoacanthoma |
|
Uterus - Uterine horn |
0 |
|
C3H/HeJ | Uterus - Uterine horn adenocarcinoma |
|
Uterus - Uterine horn |
0 |
|
C3H/HeJ | Uterus - Uterine horn adenocarcinoma |
|
Uterus - Uterine horn |
observed |
|
C3H/HeJ | Uterus - Uterine horn adenocarcinoma |
|
Uterus - Uterine horn |
observed |
|
C3H/HeJ | Uterus - Uterine horn adenocarcinoma |
|
Uterus - Uterine horn |
observed |
|
C3H/HeJ | Uterus - Uterine horn adenocarcinoma |
|
Uterus - Uterine horn |
0 |
|
C3H/HeJ | Uterus - Uterine horn adenocarcinoma |
|
Uterus - Uterine horn |
0 |
|
C3H/HeJ | Uterus - Uterine horn adenocarcinoma |
|
Uterus - Uterine horn |
observed |
|
C3HeB/FeJ | Uterus - Uterine horn adenocarcinoma |
|
Uterus - Uterine horn |
observed |
|
C3HeB/FeJ | Uterus - Uterine horn adenocarcinoma |
|
Uterus - Uterine horn |
observed |
|
C3HeB/FeJ | Uterus - Uterine horn adenocarcinoma |
|
Uterus - Uterine horn |
observed |
|
C3H/HeJ | Uterus adenocarcinoma |
|
Uterus |
0 |
|
C3H/HeJ | Uterus adenocarcinoma |
|
Uterus |
0 - observed |
|
C3H/HeJ | Uterus adenocarcinoma |
|
Uterus |
0 |
|
C3H/HeJ | Uterus adenocarcinoma |
|
Uterus |
observed |
|
C3H/HeJ | Uterus adenocarcinoma |
|
Uterus |
0 |
|
C3H/HeJ | Uterus adenocarcinoma |
|
Uterus |
0 |
|
C3H/HeJ | Uterus adenocarcinoma |
|
Uterus |
observed |
|
C3HeB/FeJ | Uterus adenocarcinoma |
|
Uterus |
0 |
|
C3HeB/FeJ | Uterus adenocarcinoma |
|
Uterus |
0 |
|
C3H/HeJ | Uterus atypia |
|
Uterus |
observed |
|
C3HeB/FeJ | Uterus atypia |
|
Uterus |
observed |
|
C3H/HeJ | Uterus preneoplastic lesion |
|
Uterus |
observed |
|
C3HeB/FeJ | Uterus preneoplastic lesion |
|
Uterus |
observed |
|
C3H/HeJ | Vagina squamous cell carcinoma |
|
Vagina |
0 |
|
C3H/HeJ | Vagina squamous cell carcinoma |
|
Vagina |
0 |
|
C3H/HeJ | Vagina squamous cell carcinoma |
|
Vagina |
0 |
|
C3H/HeJ | Vagina squamous cell carcinoma |
|
Vagina |
0 |
|
C3H/HeJ | Vagina squamous cell carcinoma |
|
Vagina |
0 |
|
C3HeB/FeJ | Vagina squamous cell carcinoma |
|
Vagina |
0 |
|
C3HeB/FeJ | Vagina squamous cell carcinoma |
|
Vagina |
observed |
|
C3HeB/FeJ | Vagina squamous cell carcinoma |
|
Vagina |
observed |